Toutes les études
RecrutementPhase I et Phase II (Intégrée) - Première administration chez l'hommeInterventionnel

A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled, first-in-human (FIH) Proof of Concept (PoC) study to evaluate the safety and efficacy of topically applied SXR1096 cream in patients with Netherton syndrome (NS)

This research is a trial into a new cream, SXR1096, for people who have Netherton syndrome, a condition that affects the skin. It's the very first time this cream will be tried in humans. The main goals are to carefully check if the cream is safe to use and if it helps make the skin condition better. We'll be comparing the new cream to a 'dummy' cream (placebo) which doesn't contain any medicine, to see if the new cream works better. We'll also be looking at how the cream affects symptoms like itching, redness, and flaking of the skin. This will help us understand if SXR1096 could be a helpful new treatment option.

En un coup d'œil

Statut
Recrutement
Phase
Phase I et Phase II (Intégrée) - Première administration chez l'homme
Sponsor
Sixera Pharma AB
Objectif d'inscription
24
Démarrer
23 oct. 2023

De quoi parle cette étude ?

This study is about a new cream, called SXR1096, that we hope might help people with Netherton syndrome. Netherton syndrome is a rare genetic skin condition that can cause red, flaky skin, severe itching, and hair problems. We are testing this cream for the very first time in people, so it's an important early step in seeing if it could become a new treatment.

Our main aims are to find out two things: first, how safe the cream is to use, and second, if it actually improves the skin symptoms caused by Netherton syndrome. To do this, some people in the study will get the new SXR1096 cream, and others will get a 'dummy' cream, which looks and feels the same but doesn't have any active medicine. This helps us understand if any improvements are genuinely due to the new cream.

We will be carefully monitoring participants for any side effects or changes in their health. We'll also be looking closely at their skin using special assessment tools to see how much their skin redness, flaking, and itching improve. We'll also measure things like how much water their skin loses and the skin's pH balance. This detailed information will help us understand if SXR1096 cream could be a safe and effective treatment for Netherton syndrome in the future.

Points clés

  • This study is testing a new cream, SXR1096, for Netherton syndrome.
  • It's the first time this cream will be used in people.
  • The main goals are to check for safety and see if skin symptoms improve.
  • Participants will apply two different creams, one with medicine, one without.
  • Regular clinic visits will monitor your health and skin condition.
  • Vous pouvez vous retirer de l'étude à tout moment sans que cela n'affecte vos soins.

Qui peut être éligible ?

To be able to take part in this study, you need to be at least 18 years old. There's no upper age limit, so adults of any age are welcome to inquire. The study is open to both men and women.

The most important requirement is that you have a diagnosis of Netherton syndrome. The research team will also check other health factors to make sure that taking part in the study is safe for you. They will explain these in more detail if you are interested.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Avez-vous 18 ans ou plus ?
  2. Do you have a diagnosis of Netherton syndrome?
  3. Are you able to attend clinic appointments regularly?
  4. Are you willing to apply creams to your skin as instructed?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you decide to take part, you'll be given two different creams to apply to different areas of your skin. One will contain the new medicine, and the other will be a 'dummy' cream with no medicine. Neither you nor the study team will know which cream is which, to ensure the results are as fair as possible. You'll use these creams for a set period of time.

Throughout the study, you'll have several visits to the clinic. At these visits, doctors and nurses will check your overall health, measure your vital signs (like blood pressure and temperature), and take blood samples. They will also carefully examine your skin, measure things like redness, flaking, and itching, and ask you about any side effects you might be having. These appointments will involve applying cream and undergoing skin assessments. The total length of your participation, including follow-up after stopping the cream, will be fully explained to you before you agree to join.

Risques et avantages potentiels

Taking part in any medical study has potential benefits and risks. A potential benefit of this study is that the new cream might improve symptoms of your Netherton syndrome, though this is not guaranteed as it's an early-stage trial. You'll also get close medical attention and monitoring throughout the study. Possible risks could include skin irritation or other side effects from the cream, or side effects from other study procedures like blood tests. All potential side effects will be explained in detail. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Emplacements (4)

Certains emplacements de site sont approximatifs. Nous améliorons cela — veuillez vérifier avec l'équipe d'essai avant de vous déplacer.
  • —
    Non vérifié
    Allemagne
  • —
    Non vérifié
    France
  • —
    Non vérifié
    Autriche
  • —
    Non vérifié
    Suède

Questions fréquentes

What is Netherton syndrome?

Netherton syndrome is a rare inherited skin condition that causes widespread red, flaky, and itchy skin, along with hair problems, from birth.

What does 'first-in-human' mean?

It means this is the first time the new cream, SXR1096, is being tested in people. It has been tested in labs and on animals before this stage.

Qu'est-ce qu'un 'placebo' ?

A placebo is a 'dummy' treatment that looks exactly like the real medicine but contains no active ingredients. It helps us see if the new medicine really works better than no treatment.

Will I know if I'm getting the real cream or the placebo?

No, this is a 'double-blind' study, meaning neither you nor the doctors will know who is getting the active cream and who is getting the placebo until after the study has finished. This helps make the results fair.

How long will the study last if I join?

The team will explain the exact duration, including how long you'll use the cream and any follow-up visits, during your first appointment. It typically involves several weeks or months.

Comment en savoir plus

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "A phase I/II, multicenter, randomized, double-blind, placebo… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.